The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Systematic elucidation of genetic mechanisms underlying cholesterol uptake
Published version of a preprint
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Individual cells with disrupted PCSK9 will remain sensitive to the extracellular PCSK9 secreted by neighboring cells, precluding their development of a LDLR-mediated phenotype in this study and in prior pooled CRISPR screens.
“For example, individual cells with disrupted PCSK9 will remain sensitive to the extracellular PCSK9 secreted by neighboring cells, precluding their development of a LDLR-mediated phenotype in this study and in prior pooled CRISPR screens for LDL uptake or LDLR abundance56,80,93.”
From Functional interrogation of cellular Lp(a) uptake by genome-scale CRISPR screening (2025) · cites this paper as [93]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
Cannon, C. P., Blazing, M. A., Giugliano, R. P., McCagg, A., White, J. A., Theroux, P., Darius, H., Lewis, B. S., Ophuis, T. O., Jukema, J. W., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1410489 · Cited by 4,487
miRDB: an online database for prediction of functional microRNA targets
Chen, Y., & Wang, X. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkz757 · Cited by 3,277
Identifying a High Fraction of the Human Genome to be under Selective Constraint Using GERP++
Davydov, E. V., Goode, D. L., Sirota, M., Cooper, G. M., Sidow, A., & Batzoglou, S. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1001025 · Cited by 1,757
High-throughput functional genomics using CRISPR-Cas9
Shalem, O., Sanjana, N. E., & Zhang, F. (2015) · Nature Reviews Genetics · doi:10.1038/nrg3899 · Cited by 1,233
High-throughput discovery of novel developmental phenotypes
The International Mouse Phenotyping Consortium, Dickinson, M. E., Flenniken, A. M., Ji, X., Teboul, L., Wong, M. D., White, J. K., Meehan, T. F., Weninger, W. J., Westerberg, H., et al. (2016) · Nature · doi:10.1038/nature19356 · Cited by 1,196
The power of genetic diversity in genome-wide association studies of lipids
Graham, S. E., Clarke, S. L., Wu, K.-H. H., Kanoni, S., Zajac, G. J. M., Ramdas, S., Surakka, I., Ntalla, I., Vedantam, S., Winkler, T. W., et al. (2021) · Nature · doi:10.1038/s41586-021-04064-3 · Cited by 972 · cited 5×
“Blue bars represent ABC predicted enhancer connections with DENND4C.”
InfluentialSelf-citationGenetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease
Dewey, F. E., Gusarova, V., Dunbar, R. L., O’Dushlaine, C., Schurmann, C., Gottesman, O., McCarthy, S., Van Hout, C. V., Bruse, S., Dansky, H. M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1612790 · Cited by 885
Mapping information-rich genotype-phenotype landscapes with genome-scale Perturb-seq
Replogle, J. M., Saunders, R. A., Pogson, A. N., Hussmann, J. A., Lenail, A., Guna, A., Mascibroda, L., Wagner, E. J., Adelman, K., Lithwick-Yanai, G., et al. (2022) · Cell · doi:10.1016/j.cell.2022.05.013 · Cited by 795 · cited 1×
“We analyzed genome-wide Perturb-seq data in which RNA-seq profiling was performed after CRISPRi knockdown of 9,858 genes in the myelogenous leukemia cell line K562.(70) While knockdown ofOTX1 andOTX2was performed in this study, the OTX2 knockdown experiment failed quality control.”
A highly durable RNAi therapeutic inhibitor of PCSK9
Fitzgerald, K., White, S., Borodovsky, A., Bettencourt, B. R., Strahs, A., Clausen, V., Wijngaard, P., Horton, J. D., Taubel, J., Brooks, A., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1609243 · Cited by 768
Viney, N. J., van Capelleveen, J. C., Geary, R. S., Xia, S., Tami, J. A., Yu, R. Z., Marcovina, S. M., Hughes, S. G., Graham, M. J., Crooke, R. M., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31009-1 · Cited by 754 · cited 1×
“Genetic findings from variants with effects on cholesterol levels have led to the development of FDA-approved drugs targeting PCSK9 and a clinical pipeline targeting ANGPTL3, APOC3, and LPA.(8,9) Nonetheless, the genetics of cholesterol levels are far from completely understood.”
Liver X receptors in lipid signalling and membrane homeostasis
Wang, B., & Tontonoz, P. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0037-x · Cited by 722
Evaluation and Design of Genome-Wide CRISPR/SpCas9 Knockout Screens
Hart, T., Tong, A. H. Y., Chan, K., Van Leeuwen, J., Seetharaman, A., Aregger, M., Chandrashekhar, M., Hustedt, N., Seth, S., Noonan, A., et al. (2017) · G3 Genes|Genomes|Genetics · doi:10.1534/g3.117.041277 · Cited by 599
Predictable and precise template-free CRISPR editing of pathogenic variants
Shen, M. W., Arbab, M., Hsu, J. Y., Worstell, D., Culbertson, S. J., Krabbe, O., Cassa, C. A., Liu, D. R., Gifford, D. K., & Sherwood, R. I. (2018) · Nature · doi:10.1038/s41586-018-0686-x · Cited by 569
Self-citationA genome-wide atlas of co-essential modules assigns function to uncharacterized genes
Wainberg, M., Kamber, R. A., Balsubramani, A., Meyers, R. M., Sinnott-Armstrong, N., Hornburg, D., Jiang, L., Chan, J., Jian, R., Gu, M., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00840-z · Cited by 204
Identification of Cholesterol-Regulating Genes by Targeted RNAi Screening
Bartz, F., Kern, L., Erz, D., Zhu, M., Gilbert, D., Meinhof, T., Wirkner, U., Erfle, H., Muckenthaler, M., Pepperkok, R., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.05.009 · Cited by 198
Fedoseienko, A., Wijers, M., Wolters, J. C., Dekker, D., Smit, M., Huijkman, N., Kloosterhuis, N., Klug, H., Schepers, A., Willems van Dijk, K., et al. (2018) · Circulation Research · doi:10.1161/circresaha.117.312004 · Cited by 126
GPR146 Deficiency Protects against Hypercholesterolemia and Atherosclerosis
Yu, H., Rimbert, A., Palmer, A. E., Toyohara, T., Xia, Y., Xia, F., Ferreira, L. M. R., Chen, Z., Chen, T., Loaiza, N., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.034 · Cited by 113
Self-citationA macrophage-hepatocyte glucocorticoid receptor axis coordinates fasting ketogenesis
Loft, A., Schmidt, S. F., Caratti, G., Stifel, U., Havelund, J., Sekar, R., Kwon, Y., Sulaj, A., Chow, K. K., Alfaro, A. J., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.01.004 · Cited by 76
Genome-scale CRISPR screening for modifiers of cellular LDL uptake
Emmer, B. T., Sherman, E. J., Lascuna, P. J., Graham, S. E., Willer, C. J., & Ginsburg, D. (2021) · PLOS Genetics · doi:10.1371/journal.pgen.1009285 · Cited by 32
Khan, T. G., Ginsburg, D., & Emmer, B. T. (2022) · Journal of Lipid Research · doi:10.1016/j.jlr.2022.100248 · Cited by 21
Flagged first, then by citations
Research works printed but not linked: 101
- 2016, Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015, Lancet, 388, 1459, 10.1016/S0140-6736(16)31012-1 · DOI · Paper page
- Mundal, 2018, Impact of age on excess risk of coronary heart disease in patients with familial hypercholesterolaemia, Heart, 104, 1600, 10.1136/heartjnl-2017-312706 · DOI
- Global Lipids Genetics Consortium, 2018, Genetics of blood lipids among ∼300,000 multi-ethnic participants of the Million Veteran Program, Nat. Genet., 50, 1514, 10.1038/s41588-018-0222-9 · DOI · Paper page
- Klarin, 2017, Genetic analysis in UK Biobank links insulin resistance and transendothelial migration pathways to coronary artery disease, Nat. Genet., 49, 1392, 10.1038/ng.3914 · DOI
- Willer, 2013, Discovery and refinement of loci associated with lipid levels, Nat. Genet., 45, 1274, 10.1038/ng.2797 · DOI
- Howson, 2017, Fifteen new risk loci for coronary artery disease highlight arterial-wall-specific mechanisms, Nat. Genet., 49, 1113, 10.1038/ng.3874 · DOI
- Nikpay, 2015, A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease, Nat. Genet., 47, 1121, 10.1038/ng.3396 · DOI · Paper page
- Musunuru, 2019, Genetics of common, complex coronary artery disease, Cell, 177, 132, 10.1016/j.cell.2019.02.015 · DOI
- Jurgens, 2022, Analysis of rare genetic variation underlying cardiometabolic diseases and traits among 200,000 individuals in the UK Biobank, Nat. Genet., 54, 240, 10.1038/s41588-021-01011-w · DOI
- Wang, 2021, Rare variant contribution to human disease in 281,104 UK Biobank exomes, Nature, 597, 527, 10.1038/s41586-021-03855-y · DOI · Paper page
- Hindy, 2022, Rare coding variants in 35 genes associate with circulating lipid levels-A multi-ancestry analysis of 170,000 exomes, Am. J. Hum. Genet., 109, 81, 10.1016/j.ajhg.2021.11.021 · DOI
- Backman, 2021, Exome sequencing and analysis of 454,787 UK Biobank participants, Nature, 599, 628, 10.1038/s41586-021-04103-z · DOI
- Berberich, 2019, The complex molecular genetics of familial hypercholesterolaemia, Nat. Rev. Cardiol., 16, 9, 10.1038/s41569-018-0052-6 · DOI
- Young, 2012, Lowering plasma cholesterol by raising LDL receptors—revisited, N. Engl. J. Med., 366, 1154, 10.1056/NEJMe1202168 · DOI
- Horton, 2002, SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver, J. Clin. Invest., 109, 1125, 10.1172/JCI0215593 · DOI · Paper page
- Blattmann, 2013, RNAi–based functional profiling of loci from blood lipid genome-wide association studies identifies genes with cholesterol-regulatory function, PLoS Genet., 9, 10.1371/journal.pgen.1003338 · DOI
- Kraehling, 2016, Genome-wide RNAi screen reveals ALK1 mediates LDL uptake and transcytosis in endothelial cells, Nat. Commun., 7, 10.1038/ncomms13516 · DOI · Paper page
- Thormaehlen, 2015, Systematic cell-based phenotyping of missense alleles empowers rare variant association studies: a case for LDLR and myocardial infarction, PLoS Genet., 11, 10.1371/journal.pgen.1004855 · DOI
- Aden, 1979, Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line, Nature, 282, 615, 10.1038/282615a0 · DOI
- Zhou, 2019, Haplotype-resolved and integrated genome analysis of the cancer cell line HepG2, Nucleic Acids Res., 47, 3846, 10.1093/nar/gkz169 · DOI · Paper page
- Partridge, 2020, Occupancy maps of 208 chromatin-associated proteins in one human cell type, Nature, 583, 720, 10.1038/s41586-020-2023-4 · DOI · Paper page
- Zelcer, 2009, LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor, Science, 325, 100, 10.1126/science.1168974 · DOI · Paper page
- Joung, 2017, Genome-scale CRISPR-cas9 knockout and transcriptional activation screening, Nat. Protoc., 12, 828, 10.1038/nprot.2017.016 · DOI · Paper page
- Wang, 2019, Integrative analysis of pooled CRISPR genetic screens using MAGeCKFlute, Nat. Protoc., 14, 756, 10.1038/s41596-018-0113-7 · DOI
- Lambert, 2018, The human transcription factors, Cell, 172, 650, 10.1016/j.cell.2018.01.029 · DOI · Paper page
- Lin, 2020, Comprehensive mapping of key regulatory networks that drive oncogene expression, Cell Rep., 33, 10.1016/j.celrep.2020.108426 · DOI
- Lucero, 2022, Transgelin: a new gene involved in LDL endocytosis identified by a genome-wide CRISPR-Cas9 screen, J. Lipid Res., 63, 100160, 10.1016/j.jlr.2021.100160 · DOI
- Smith, 2021, CSDE1 is a post-transcriptional regulator of the LDL receptor, bioRxiv
- Ye, 2011, Regulation of cholesterol and fatty acid synthesis, Cold Spring Harb. Perspect. Biol., 3, 10.1101/cshperspect.a004754 · DOI · Paper page
- Yin, 2011, Hepatic HNF4α is essential for maintaining triglyceride and cholesterol homeostasis, Arterioscler. Thromb. Vasc. Biol., 31, 328, 10.1161/ATVBAHA.110.217828 · DOI
- Luo, 2020, Mechanisms and regulation of cholesterol homeostasis, Nat. Rev. Mol. Cell Biol., 21, 225, 10.1038/s41580-019-0190-7 · DOI · Paper page
- Tanenbaum, 2014, A protein-tagging system for signal amplification in gene expression and fluorescence imaging, Cell, 159, 635, 10.1016/j.cell.2014.09.039 · DOI
- Konermann, 2015, Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex, Nature, 517, 583, 10.1038/nature14136 · DOI · Paper page
- Sanson, 2018, Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalities, Nat. Commun., 9, 5416, 10.1038/s41467-018-07901-8 · DOI · Paper page
- Kim, 2019, SpCas9 activity prediction by DeepSpCas9, a deep learning–based model with high generalization performance, Sci. Adv., 5, 10.1126/sciadv.aax9249 · DOI
- Doench, 2016, Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9, Nat. Biotechnol., 34, 184, 10.1038/nbt.3437 · DOI · Paper page
- Tsherniak, 2017, Defining a cancer dependency Map, Cell, 170, 564, 10.1016/j.cell.2017.06.010 · DOI · Paper page
- Boyle, 2018, High-resolution mapping of cancer cell networks using co-functional interactions, Mol. Syst. Biol., 14, 10.15252/msb.20188594 · DOI
- Kim, 2019, A network of human functional gene interactions from knockout fitness screens in cancer cells, Life Sci. Alliance, 2, 10.26508/lsa.201800278 · DOI
- Wang, 2017, Gene essentiality profiling reveals gene networks and synthetic lethal interactions with oncogenic ras, Cell, 42, 890, 10.1016/j.cell.2017.01.013 · DOI · Paper page
- Amici, 2021, FIREWORKS: a bottom-up approach to integrative coessentiality network analysis, Life Sci. Alliance, 4, 10.26508/lsa.202000882 · DOI
- Nepusz, 2012, Detecting overlapping protein complexes in protein-protein interaction networks, Nat. Methods, 9, 471, 10.1038/nmeth.1938 · DOI
- Chua, 2018, Rab 10-a traffic controller in multiple cellular pathways and locations, J. Cell. Physiol., 233, 6483, 10.1002/jcp.26503 · DOI · Paper page
- Gulbranson, 2017, RABIF/MSS4 is a Rab-stabilizing holdase chaperone required for GLUT4 exocytosis, Proc. Natl. Acad. Sci., 114, E8224, 10.1073/pnas.1712176114 · DOI · Paper page
- Sano, 2011, Insulin-stimulated GLUT4 protein translocation in adipocytes requires the Rab10 guanine nucleotide exchange factor Dennd4C, J. Biol. Chem., 286, 16541, 10.1074/jbc.C111.228908 · DOI
- Zeng, 2017, Polarized exocytosis, Cold Spring Harb. Perspect. Biol., 9, 10.1101/cshperspect.a027870 · DOI
- Islam, 2022, Low-density lipoprotein internalization, degradation and receptor recycling along membrane contact sites, Front. Cell Dev. Biol., 10, 826379, 10.3389/fcell.2022.826379 · DOI
- Grindstaff, 1998, Sec6/8 complex is recruited to cell-cell contacts and specifies transport vesicle delivery to the basal-lateral membrane in epithelial cells, Cell, 93, 731, 10.1016/S0092-8674(00)81435-X · DOI · Paper page
- Bermudez-Cabrera, 2021, Small molecule inhibition of ATM kinase increases CRISPR-Cas9 1-bp insertion frequency, Nat. Commun., 12, 5111, 10.1038/s41467-021-25415-8 · DOI
- McDermott, 2019, Large-scale compound screens and pharmacogenomic interactions in cancer, Curr. Opin. Genet. Dev., 54, 12, 10.1016/j.gde.2019.02.002 · DOI
- Bycroft, 2018, The UK Biobank resource with deep phenotyping and genomic data, Nature, 562, 203, 10.1038/s41586-018-0579-z · DOI · Paper page
- Hung, 2012, Gene set enrichment analysis: performance evaluation and usage guidelines, Brief. Bioinform., 13, 281, 10.1093/bib/bbr049 · DOI
- Povysil, 2019, Rare-variant collapsing analyses for complex traits: guidelines and applications, Nat. Rev. Genet., 20, 747, 10.1038/s41576-019-0177-4 · DOI
- Kircher, 2014, A general framework for estimating the relative pathogenicity of human genetic variants, Nat. Genet., 46, 310, 10.1038/ng.2892 · DOI · Paper page
- Carter, 2013, Identifying Mendelian disease genes with the variant effect scoring tool, BMC Genom., 14, S3, 10.1186/1471-2164-14-S3-S3 · DOI
- Pollard, 2010, Detection of nonneutral substitution rates on mammalian phylogenies, Genome Res., 20, 110, 10.1101/gr.097857.109 · DOI · Paper page
- Landrum, 2014, ClinVar: public archive of relationships among sequence variation and human phenotype, Nucleic Acids Res., 42, D980, 10.1093/nar/gkt1113 · DOI · Paper page
- Cohen, 2006, Sequence variations in PCSK9, low LDL, and protection against coronary heart disease, N. Engl. J. Med., 354, 1264, 10.1056/NEJMoa054013 · DOI · Paper page
- ENCODE Project Consortium, 2012, An integrated encyclopedia of DNA elements in the human genome, Nature, 489, 57, 10.1038/nature11247 · DOI · Paper page
- McLean, 2010, GREAT improves functional interpretation of cis-regulatory regions, Nat. Biotechnol., 28, 495, 10.1038/nbt.1630 · DOI · Paper page
- Koornneef, 2011, Apolipoprotein B knockdown by AAV-delivered shRNA lowers plasma cholesterol in mice, Mol. Ther., 19, 731, 10.1038/mt.2011.6 · DOI
- Lei, 2016, Increased hepatic fatty acids uptake and oxidation by LRPPRC-driven oxidative phosphorylation reduces blood lipid levels, Front. Physiol., 7, 270, 10.3389/fphys.2016.00270 · DOI
- Ding, 2014, Permanent alteration of PCSK9 with in vivo CRISPR-cas9 genome editing, Circ. Res., 115, 488, 10.1161/CIRCRESAHA.115.304351 · DOI · Paper page
- Frank-Kamenetsky, 2008, Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates, Proc. Natl. Acad. Sci. USA, 105, 11915, 10.1073/pnas.0805434105 · DOI
- Welty, 2020, Hypobetalipoproteinemia and abetalipoproteinemia: liver disease and cardiovascular disease, Curr. Opin. Lipidol., 31, 49, 10.1097/MOL.0000000000000663 · DOI
- Wellcome Trust Case Control Consortium, 2012, Bayesian refinement of association signals for 14 loci in 3 common diseases, Nat. Genet., 44, 1294, 10.1038/ng.2435 · DOI
- Moore, 2019, Arid1a loss drives nonalcoholic steatohepatitis in mice through epigenetic dysregulation of hepatic lipogenesis and fatty acid oxidation, Hepatology, 69, 1931, 10.1002/hep.30487 · DOI
- Ramdas, 2021, A multi-layer functional genomic analysis to understand noncoding genetic variation in lipids, Genomics, 109, 1366
- Anastasia, 2021, Mitochondria-rough-ER contacts in the liver regulate systemic lipid homeostasis, Cell Rep., 34, 10.1016/j.celrep.2021.108873 · DOI
- MÜLLER, 1939, Angina pectoris in hereditary xanthomatosis, Arch. Intern. Med., 64, 675, 10.1001/archinte.1939.00190040016002 · DOI
- Wilson, 2013, Lipids and vascular disease: a framingham perspective, Glob. Heart, 8, 25, 10.1016/j.gheart.2012.12.009 · DOI
- Acampora, 1995, Forebrain and midbrain regions are deleted in Otx2-/- mutants due to a defective anterior neuroectoderm specification during gastrulation, Dev. Camb. Engl., 121, 3279
- Nada, 1993, Constitutive activation of Src family kinases in mouse embryos that lack Csk, Cell, 73, 1125, 10.1016/0092-8674(93)90642-4 · DOI
- Lv, 2015, Targeted disruption of Rab10 causes early embryonic lethality, Protein Cell, 6, 463, 10.1007/s13238-015-0150-8 · DOI · Paper page
- Li, 2016, A novel Rab10-EHBP1-EHD2 complex essential for the autophagic engulfment of lipid droplets, Sci. Adv., 2, 10.1126/sciadv.1601470 · DOI
- Suda, 1999, Functional equivalency between Otx2 and Otx1 in development of the rostral head, Development, 126, 743, 10.1242/dev.126.4.743 · DOI
- Lee, 2012, Optimal unified approach for rare-variant association testing with application to small-sample case-control whole-exome sequencing studies, Am. J. Hum. Genet., 91, 224, 10.1016/j.ajhg.2012.06.007 · DOI
- Sanjana, 2014, Improved vectors and genome-wide libraries for CRISPR screening, Nat. Methods, 11, 783, 10.1038/nmeth.3047 · DOI · Paper page
- Jeng, 2019, Systematic Identification of Host Cell Regulators of Legionella pneumophila Pathogenesis Using a Genome-wide CRISPR Screen, Cell Host & Microbe, ISSN 1931-3128, 26, 551
- Li, 2014, MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens, Genome Biol., 15, 554, 10.1186/s13059-014-0554-4 · DOI · Paper page
- Erard, 2017, A CRISPR resource for individual, combinatorial, or Multiplexed gene knockout, Mol. Cell, 67, 348, 10.1016/j.molcel.2017.06.030 · DOI
- Chen, 2013, Dynamic imaging of genomic loci in living human cells by an optimized CRISPR/Cas system, Cell, 155, 1479, 10.1016/j.cell.2013.12.001 · DOI
- Bushnell, 2017, BBMerge – accurate paired shotgun read merging via overlap, PLoS One, 12, 10.1371/journal.pone.0185056 · DOI
- Dobin, 2013, STAR: ultrafast universal RNA-seq aligner, Bioinforma. Oxf. Engl., 29, 15, 10.1093/bioinformatics/bts635 · DOI · Paper page
- Anders, 2015, HTSeq--a Python framework to work with high-throughput sequencing data, Bioinforma. Oxf. Engl., 31, 166, 10.1093/bioinformatics/btu638 · DOI · Paper page
- Virtanen, 2020, SciPy 1.0: fundamental algorithms for scientific computing in Python, Nat. Methods, 17, 261, 10.1038/s41592-019-0686-2 · DOI · Paper page
- Ashburner, 2000, Gene Ontology: tool for the unification of biology, Nat. Genet., 25, 25, 10.1038/75556 · DOI · Paper page
- Mi, 2019, PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools, Nucleic Acids Res., 47, D419, 10.1093/nar/gky1038 · DOI
- van der Maaten, 2008, Visualizing Data using t-SNE, J. Mach. Learn. Res., 9, 2579
- 2022, Hail
- Karczewski, 2020, The mutational constraint spectrum quantified from variation in 141,456 humans, Nature, 581, 434, 10.1038/s41586-020-2308-7 · DOI · Paper page
- Cunningham, 2022, Ensembl 2022, Nucleic Acids Res., 50, D988, 10.1093/nar/gkab1049 · DOI · Paper page
- McLaren, 2016, The ensembl variant effect predictor, Genome Biol., 17, 122, 10.1186/s13059-016-0974-4 · DOI · Paper page
- Liu, 2020, dbNSFP v4: a comprehensive database of transcript-specific functional predictions and annotations for human nonsynonymous and splice-site SNVs, Genome Med., 12, 103, 10.1186/s13073-020-00803-9 · DOI
- Pedregosa, 2011, Scikit-learn: Machine learning in Python, J. Mach. Learn. Res., 12, 2825
- Davidson-Pilon, 2019, lifelines: survival analysis in Python, J. Open Source Softw., 4, 1317, 10.21105/joss.01317 · DOI
- Szustakowski, 2021, Advancing human genetics research and drug discovery through exome sequencing of the UK Biobank, Nat. Genet., 53, 942, 10.1038/s41588-021-00885-0 · DOI · Paper page
- Patel, 2020, Association of rare pathogenic DNA variants for familial hypercholesterolemia, hereditary breast and ovarian cancer syndrome, and lynch syndrome with disease risk in adults according to family history, JAMA Netw. Open, 3, 10.1001/jamanetworkopen.2020.3959 · DOI
- Lee, 2011, The transcription factor cyclic AMP–responsive element–binding protein H regulates triglyceride metabolism, Nat. Med., 17, 812, 10.1038/nm.2347 · DOI
- Benjamini, 1995, Controlling the false discovery rate: a practical and powerful approach to multiple testing, J. R. Stat. Soc. Ser. B Methodol., 57, 289, 10.1111/j.2517-6161.1995.tb02031.x · DOI · Paper page
- Sarkar, 1997, The Simes method for multiple hypothesis testing with positively dependent test statistics, J. Am. Stat. Assoc., 92, 1601, 10.1080/01621459.1997.10473682 · DOI
Cited by
Sorted by citations
Functional interrogation of cellular Lp(a) uptake by genome-scale CRISPR screening
Khan, T. G., Bragazzi Cunha, J., Raut, C., Burroughs, M., Vyas, H. S., Leix, K., Goonewardena, S. N., Smrcka, A. V., Speliotes, E. K., & Emmer, B. T. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.119174 · Cited by 6
Metadata
- Authors
- Hamilton, M. C., Fife, J. D., Akinci, E., Yu, T., Khowpinitchai, B., Cha, M., Barkal, S., Thi, T. T., Yeo, G. H. T., Ramos Barroso, J. P., Francoeur, M. J., Velimirovic, M., Gifford, D. K., Lettre, G., Yu, H., Cassa, C. A., & Sherwood, R. I.
- ORCID
- Sherwood, Richard I.
- Venue
- Cell Genomics
- Publisher
- Elsevier BV
- Published
- 2023-05
- Volume
- 3
- Issue
- 5
- Pages
- 100304
- ISSN
- 2666-979X
- PMC
- PMC10203276
- Cited by
- 16
- References
- 21
- Language
- en
- Licence
- Funders
- National Organization for Rare Disorders
- Qatar Biomedical Research Institute, Hamad Bin Khalifa University
- National University of Singapore
- NIH (1R01HG008754, 1R21HG010391, R01HG010372)
- American Cancer Society
- American Heart Association
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review